Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1999 Jan-Feb;5(1):9–17. doi: 10.3201/eid0501.990102

The economic impact of Staphylococcus aureus infection in New York City hospitals.

R J Rubin 1, C A Harrington 1, A Poon 1, K Dietrich 1, J A Greene 1, A Moiduddin 1
PMCID: PMC2627695  PMID: 10081667

Abstract

We modeled estimates of the incidence, deaths, and direct medical costs of Staphylococcus aureus infections in hospitalized patients in the New York City metropolitan area in 1995 by using hospital discharge data collected by the New York State Department of Health and standard sources for the costs of health care. We also examined the relative impact of methicillin-resistant versus -sensitive strains of S. aureus and of community-acquired versus nosocomial infections. S. aureus-associated hospitalizations resulted in approximately twice the length of stay, deaths, and medical costs of typical hospitalizations; methicillin-resistant and -sensitive infections had similar direct medical costs, but resistant infections caused more deaths (21% versus 8%). Community-acquired and nosocomial infections had similar death rates, but community-acquired infections appeared to have increased direct medical costs per patient ($35,300 versus $28,800). The results of our study indicate that reducing the incidence of methicillin-resistant and -sensitive nosocomial infections would reduce the societal costs of S. aureus infection.

Full Text

The Full Text of this article is available as a PDF (73.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett F. F., McGehee R. F., Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med. 1968 Aug 29;279(9):441–448. doi: 10.1056/NEJM196808292790901. [DOI] [PubMed] [Google Scholar]
  2. Boyce J. M. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol. 1990 Dec;11(12):639–642. doi: 10.1086/646114. [DOI] [PubMed] [Google Scholar]
  3. Boyce J. M., Jackson M. M., Pugliese G., Batt M. D., Fleming D., Garner J. S., Hartstein A. I., Kauffman C. A., Simmons M., Weinstein R. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol. 1994 Feb;15(2):105–115. doi: 10.1086/646870. [DOI] [PubMed] [Google Scholar]
  4. Bradley S. F. Methicillin-resistant Staphylococcus aureus infection. Clin Geriatr Med. 1992 Nov;8(4):853–868. [PubMed] [Google Scholar]
  5. Centers for Disease Control and Prevention (CDC) Nosocomial enterococci resistant to vancomycin--United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993 Aug 6;42(30):597–599. [PubMed] [Google Scholar]
  6. Fagon J. Y., Chastre J., Hance A. J., Montravers P., Novara A., Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993 Mar;94(3):281–288. doi: 10.1016/0002-9343(93)90060-3. [DOI] [PubMed] [Google Scholar]
  7. Fagon J. Y., Chastre J., Vuagnat A., Trouillet J. L., Novara A., Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA. 1996 Mar 20;275(11):866–869. [PubMed] [Google Scholar]
  8. Haley R. W., Culver D. H., White J. W., Morgan W. M., Emori T. G. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol. 1985 Feb;121(2):159–167. doi: 10.1093/oxfordjournals.aje.a113988. [DOI] [PubMed] [Google Scholar]
  9. Jarvis W. R. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol. 1996 Aug;17(8):552–557. doi: 10.1086/647371. [DOI] [PubMed] [Google Scholar]
  10. Lavery L. A., Sariaya M., Ashry H., Harkless L. B. Microbiology of osteomyelitis in diabetic foot infections. J Foot Ankle Surg. 1995 Jan-Feb;34(1):61–64. doi: 10.1016/S1067-2516(09)80103-8. [DOI] [PubMed] [Google Scholar]
  11. Leu H. S., Kaiser D. L., Mori M., Woolson R. F., Wenzel R. P. Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol. 1989 Jun;129(6):1258–1267. doi: 10.1093/oxfordjournals.aje.a115245. [DOI] [PubMed] [Google Scholar]
  12. McManus A. T., Mason A. D., Jr, McManus W. F., Pruitt B. A., Jr What's in a name? Is methicillin-resistant Staphylococcus aureus just another S aureus when treated with vancomycin? Arch Surg. 1989 Dec;124(12):1456–1459. doi: 10.1001/archsurg.1989.01410120106020. [DOI] [PubMed] [Google Scholar]
  13. Muder R. R., Brennen C., Wagener M. M., Goetz A. M. Bacteremia in a long-term-care facility: a five-year prospective study of 163 consecutive episodes. Clin Infect Dis. 1992 Mar;14(3):647–654. doi: 10.1093/clinids/14.3.647. [DOI] [PubMed] [Google Scholar]
  14. Neu H. C. The crisis in antibiotic resistance. Science. 1992 Aug 21;257(5073):1064–1073. doi: 10.1126/science.257.5073.1064. [DOI] [PubMed] [Google Scholar]
  15. Panlilio A. L., Culver D. H., Gaynes R. P., Banerjee S., Henderson T. S., Tolson J. S., Martone W. J. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol. 1992 Oct;13(10):582–586. doi: 10.1086/646432. [DOI] [PubMed] [Google Scholar]
  16. Papazian L., Bregeon F., Thirion X., Gregoire R., Saux P., Denis J. P., Perin G., Charrel J., Dumon J. F., Affray J. P. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med. 1996 Jul;154(1):91–97. doi: 10.1164/ajrccm.154.1.8680705. [DOI] [PubMed] [Google Scholar]
  17. Pittet D., Waldvogel F. A. To control or not to control colonization with MRSA ... that's the question! QJM. 1997 Apr;90(4):239–241. doi: 10.1093/qjmed/90.4.239. [DOI] [PubMed] [Google Scholar]
  18. Wakefield D. S., Pfaller M. A., Hammons G. T., Massanari R. M. Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infections. Med Care. 1987 Jun;25(6):481–488. doi: 10.1097/00005650-198706000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES